论文部分内容阅读
目的：探讨选择阿莫西林+果胶铋对胃炎患者加以治疗后获得的临床效果。方法：选择我院2014年09月～2016年09月收治的胃炎患者71例作为本次实验对比观察对象；分组依据为胃炎疾病治疗方法不同；观察组（36例）：阿莫西林+果胶铋；对照组（35例）：克拉霉素+果胶铋；对比胃炎治疗总有效率以及幽门螺杆菌清除率。结果：在治疗总有效率以及幽门螺杆菌清除率两方面，两组胃炎患者之间凸显差异（P<0.05）。结论：对于胃炎患者，治疗药物选择阿莫西林+果胶铋，可以成功将胃炎疗效以及幽门螺杆菌清除率提高，进而显著促进胃炎患者疾病康复。“,”Objective:To study the choice of amoxicil in plus pectic bismuth obtained clinical effect after treatment in patients with gastritis.Methods:From sep 2014 to sep 2016 treated 71 cases of patients with gastritis as this experiment contrast observation object;Grouping based on gastritis disease treatment;Observation group (36 cases):amoxicil in plus pectic bismuth;The control group (35 cases):clarithromycin+pectic bismuth;Compared with gastritis total effective rate and clearance of helicobacter pylori.Results:The total effective rate in treatment and helicobacter pylori clearance rate two aspects, highlightin g differences between two groups of patients with gastritis (P<0.05).Conclusion:For patients with gastritis, treatment choice o f amoxicil in plus pectic bismuth, can success wil gastritis and helicobacter pylori clearance to improve curative effect, and significantly improve patients with gastritis disease rehabilitation.